Abstract
ABSTRACTWe present a pipeline to quantify biomechanical environment of the brain using solely MRI-derived data in order to elucidate the role of biomechanical factors in neurodegenerative disorders. Neurological disorders, like Alzheimer’s and Parkinson’s diseases, are associated with physical changes, including the accumulation of amyloid-β and tau proteins, damage to the cerebral vasculature, hypertension, atrophy of the cortical gray matter, and lesions of the periventricular white matter. Alterations in the external mechanical environment of cells can trigger pathological processes, and it is known that AD causes reduced stiffness in the brain tissue during degeneration. However, there appears to be a significant lag time between microscale changes and macroscale obstruction of neurological function in the brain. Here, we present a pipeline to quantify the whole brain biomechanical environment to bridge the gap in understanding how underlying brain changes affect macroscale brain biomechanics. This pipeline enables image-based quantification of subject-specific displacement field of the whole brain to subject-specific strain, strain rate, and stress across 133 labeled functional brain regions. We have focused our development efforts on utilizing solely MRI-derived data to facilitate clinical applicability of our approach and have emphasized automation in all aspects of our methods to reduce operator dependance. Our pipeline has the potential to improve early detection of neurological disorders and facilitate the identification of disease before widespread, irreversible damage has occurred.
Publisher
Cold Spring Harbor Laboratory
Reference53 articles.
1. Soria Lopez, J. A. , González, H. M. , and Léger, G. C. , 2019, “Alzheimer’s Disease,” Handbook of Clinical Neurology, pp. 231–255.
2. 2023 Alzheimer’s Disease Facts and Figures;Alzheimer’s & Dementia,2023
3. Amyloid Precursor Protein Processing and Alzheimer's Disease
4. Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer’s Disease;Acta Neuropathol Commun,2014
5. Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade;Journal of Alzheimer’s Disease,2018